KS
Kumar Saurabh
About Kumar Saurabh
Data last updated:
Kumar Saurabh is a Director at Brainkem Biotech Private Limited (since 2022) and Director at Neurotroph Healthcare Private Limited (since 2026). The companies operate in Chemicals. The largest current company by reported revenue is Brainkem Biotech Private Limited at ₹24.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Oct 2022 | 2022 | ₹24.8 Lakh (FY 2025) | Active | |
| Director | 19 Jan 2026 | 2026 | Active |
Board colleagues of Kumar Saurabh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhay Kumar | 09777688 | Brainkem Biotech Private Limited | Director |
| Wasim Raza | 09777689 | Brainkem Biotech Private Limited | Director |
| Bibi Maryam | 11493088 | Neurotroph Healthcare Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kumar Saurabh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kumar Saurabh
Kumar Saurabh currently holds 2 directorships: Brainkem Biotech Private Limited (Director, since 31 Oct 2022, revenue ₹24.8 Lakh (FY 2025)); Neurotroph Healthcare Private Limited (Director, since 19 Jan 2026).
Kumar Saurabh was first appointed on 31 Oct 2022 as Director at Brainkem Biotech Private Limited. The most recent appointment on record is 19 Jan 2026 at Neurotroph Healthcare Private Limited.
The current boards of Kumar Saurabh's companies include Abhay Kumar (Brainkem Biotech Private Limited), Wasim Raza (Brainkem Biotech Private Limited), Bibi Maryam (Neurotroph Healthcare Private Limited).